New data from Clene Nanomedicine has shown promising results for the treatment CNM-Au8® in ALS patients. Released on December 4, 2025, the analysis revealed a notable increase in survival rates. I AM ALS expressed enthusiasm for these findings, which indicate the potential for continued progress in combating the disease. The study marks a significant step forward in the fight against ALS, with the treatment showing promise in improving outcomes for patients.